Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 85 entries
Sorted by: Best Match Show Resources per page
The PI3K-PKB/Akt pathway.

Cold Spring Harbor perspectives in biology

Hemmings BA, Restuccia DF.
PMID: 25833846
Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4). doi: 10.1101/cshperspect.a026609.

No abstract available.

Cite
Hemmings BA, Restuccia DF. The PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 2015;7(4)doi: 10.1101/cshperspect.a026609.
Hemmings, B. A., & Restuccia, D. F. (2015). The PI3K-PKB/Akt pathway. Cold Spring Harbor perspectives in biology, 7(4), . https://doi.org/10.1101/cshperspect.a026609
Hemmings, Brian A, and Restuccia, David F. "The PI3K-PKB/Akt pathway." Cold Spring Harbor perspectives in biology vol. 7,4 (2015). doi: https://doi.org/10.1101/cshperspect.a026609
Hemmings BA, Restuccia DF. The PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4). doi: 10.1101/cshperspect.a026609. PMID: 25833846; PMCID: PMC4382735.
Copy Download .nbib Format: NLM
A PUBS Case in a Palliative Care Unit Experience.

Case reports in oncological medicine

Restuccia MR, Blasi M.
PMID: 25317348
Case Rep Oncol Med. 2014;2014:169782. doi: 10.1155/2014/169782. Epub 2014 Sep 15.

Purple urine bag syndrome (PUBS) is a rare condition in which purple discoloration of the collecting bag and its associated tubing occurs. It is considered a benign condition. PUBS is usually associated with urinary tract infection occurring in elderly...

Cite
Restuccia MR, Blasi M. A PUBS Case in a Palliative Care Unit Experience. Case Rep Oncol Med. 2014;2014:169782doi: 10.1155/2014/169782.
Restuccia, M. R., & Blasi, M. (2014). A PUBS Case in a Palliative Care Unit Experience. Case reports in oncological medicine, 2014169782. https://doi.org/10.1155/2014/169782
Restuccia, M R, and Blasi, M. "A PUBS Case in a Palliative Care Unit Experience." Case reports in oncological medicine vol. 2014 (2014): 169782. doi: https://doi.org/10.1155/2014/169782
Restuccia MR, Blasi M. A PUBS Case in a Palliative Care Unit Experience. Case Rep Oncol Med. 2014;2014:169782. doi: 10.1155/2014/169782. Epub 2014 Sep 15. PMID: 25317348; PMCID: PMC4181899.
Copy Download .nbib Format: NLM
Synthesis and characterization of a (+)-catechin and L-(+)-ascorbic acid cocrystal as a new functional ingredient for tea drinks.

Heliyon

Spizzirri UG, Carullo G, De Cicco L, Crispini A, Scarpelli F, Restuccia D, Aiello F.
PMID: 31463397
Heliyon. 2019 Aug 20;5(8):e02291. doi: 10.1016/j.heliyon.2019.e02291. eCollection 2019 Aug.

Tea (

Cite
Spizzirri UG, Carullo G, De Cicco L, et al. Synthesis and characterization of a (+)-catechin and L-(+)-ascorbic acid cocrystal as a new functional ingredient for tea drinks. Heliyon. 2019;5(8):e02291doi: 10.1016/j.heliyon.2019.e02291.
Spizzirri, U. G., Carullo, G., De Cicco, L., Crispini, A., Scarpelli, F., Restuccia, D., & Aiello, F. (2019). Synthesis and characterization of a (+)-catechin and L-(+)-ascorbic acid cocrystal as a new functional ingredient for tea drinks. Heliyon, 5(8), e02291. https://doi.org/10.1016/j.heliyon.2019.e02291
Spizzirri, U G, et al. "Synthesis and characterization of a (+)-catechin and L-(+)-ascorbic acid cocrystal as a new functional ingredient for tea drinks." Heliyon vol. 5,8 (2019): e02291. doi: https://doi.org/10.1016/j.heliyon.2019.e02291
Spizzirri UG, Carullo G, De Cicco L, Crispini A, Scarpelli F, Restuccia D, Aiello F. Synthesis and characterization of a (+)-catechin and L-(+)-ascorbic acid cocrystal as a new functional ingredient for tea drinks. Heliyon. 2019 Aug 20;5(8):e02291. doi: 10.1016/j.heliyon.2019.e02291. eCollection 2019 Aug. PMID: 31463397; PMCID: PMC6709408.
Copy Download .nbib Format: NLM
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.

Journal of hematology & oncology

Festuccia C, Mancini A, Colapietro A, Gravina GL, Vitale F, Marampon F, Delle Monache S, Pompili S, Cristiano L, Vetuschi A, Tombolini V, Chen Y, Mehrling T.
PMID: 29540202
J Hematol Oncol. 2018 Mar 14;11(1):38. doi: 10.1186/s13045-018-0587-3.

The original article [1] contained an error whereby Fig. 4 displayed incorrect magnification scales.

Cite
Festuccia C, Mancini A, Colapietro A, et al. Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. J Hematol Oncol. 2018;11(1):38doi: 10.1186/s13045-018-0587-3.
Festuccia, C., Mancini, A., Colapietro, A., Gravina, G. L., Vitale, F., Marampon, F., Delle Monache, S., Pompili, S., Cristiano, L., Vetuschi, A., Tombolini, V., Chen, Y., & Mehrling, T. (2018). Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. Journal of hematology & oncology, 11(1), 38. https://doi.org/10.1186/s13045-018-0587-3
Festuccia, C, et al. "Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma." Journal of hematology & oncology vol. 11,1 (2018): 38. doi: https://doi.org/10.1186/s13045-018-0587-3
Festuccia C, Mancini A, Colapietro A, Gravina GL, Vitale F, Marampon F, Delle Monache S, Pompili S, Cristiano L, Vetuschi A, Tombolini V, Chen Y, Mehrling T. Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. J Hematol Oncol. 2018 Mar 14;11(1):38. doi: 10.1186/s13045-018-0587-3. PMID: 29540202; PMCID: PMC5853051.
Copy Download .nbib Format: NLM
Structural Ordering of Molybdenum Disulfide Studied via Reactive Molecular Dynamics Simulations.

ACS applied materials & interfaces

Nicolini P, Capozza R, Restuccia P, Polcar T.
PMID: 29460632
ACS Appl Mater Interfaces. 2018 Mar 14;10(10):8937-8946. doi: 10.1021/acsami.7b17960. Epub 2018 Mar 01.

Molybdenum disulfide (MoS

Cite
Nicolini P, Capozza R, Restuccia P, et al. Structural Ordering of Molybdenum Disulfide Studied via Reactive Molecular Dynamics Simulations. ACS Appl Mater Interfaces. 2018;10(10):8937-8946doi: 10.1021/acsami.7b17960.
Nicolini, P., Capozza, R., Restuccia, P., & Polcar, T. (2018). Structural Ordering of Molybdenum Disulfide Studied via Reactive Molecular Dynamics Simulations. ACS applied materials & interfaces, 10(10), 8937-8946. https://doi.org/10.1021/acsami.7b17960
Nicolini, Paolo, et al. "Structural Ordering of Molybdenum Disulfide Studied via Reactive Molecular Dynamics Simulations." ACS applied materials & interfaces vol. 10,10 (2018): 8937-8946. doi: https://doi.org/10.1021/acsami.7b17960
Nicolini P, Capozza R, Restuccia P, Polcar T. Structural Ordering of Molybdenum Disulfide Studied via Reactive Molecular Dynamics Simulations. ACS Appl Mater Interfaces. 2018 Mar 14;10(10):8937-8946. doi: 10.1021/acsami.7b17960. Epub 2018 Mar 01. PMID: 29460632.
Copy Download .nbib Format: NLM
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.

Oncotarget

Festuccia C, Gravina GL, Giorgio C, Mancini A, Pellegrini C, Colapietro A, Delle Monache S, Maturo MG, Sferra R, Chiodelli P, Rusnati M, Cantoni A, Castelli R, Vacondio F, Lodola A, Tognolini M.
PMID: 29849945
Oncotarget. 2018 May 11;9(36):24347-24363. doi: 10.18632/oncotarget.25272. eCollection 2018 May 11.

Glioblastoma multiforme (GBM) is the most malignant brain tumor, showing high resistance to standard therapeutic approaches that combine surgery, radiotherapy, and chemotherapy. As opposed to healthy tissues, EphA2 has been found highly expressed in specimens of glioblastoma, and increased...

Cite
Festuccia C, Gravina GL, Giorgio C, et al. UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice. Oncotarget. 2018;9(36):24347-24363doi: 10.18632/oncotarget.25272.
Festuccia, C., Gravina, G. L., Giorgio, C., Mancini, A., Pellegrini, C., Colapietro, A., Delle Monache, S., Maturo, M. G., Sferra, R., Chiodelli, P., Rusnati, M., Cantoni, A., Castelli, R., Vacondio, F., Lodola, A., & Tognolini, M. (2018). UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice. Oncotarget, 9(36), 24347-24363. https://doi.org/10.18632/oncotarget.25272
Festuccia, Claudio, et al. "UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice." Oncotarget vol. 9,36 (2018): 24347-24363. doi: https://doi.org/10.18632/oncotarget.25272
Festuccia C, Gravina GL, Giorgio C, Mancini A, Pellegrini C, Colapietro A, Delle Monache S, Maturo MG, Sferra R, Chiodelli P, Rusnati M, Cantoni A, Castelli R, Vacondio F, Lodola A, Tognolini M. UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice. Oncotarget. 2018 May 11;9(36):24347-24363. doi: 10.18632/oncotarget.25272. eCollection 2018 May 11. PMID: 29849945; PMCID: PMC5966254.
Copy Download .nbib Format: NLM
Sangiovese .

Antioxidants (Basel, Switzerland)

Carullo G, Governa P, Spizzirri UG, Biagi M, Sciubba F, Giorgi G, Loizzo MR, Di Cocco ME, Aiello F, Restuccia D.
PMID: 31936207
Antioxidants (Basel). 2020 Jan 08;9(1). doi: 10.3390/antiox9010054.

Inflammatory bowel disease and food allergies are a growing topic in the field of nutrition science. Polyphenols, which are the most important secondary metabolites of plants, demonstrated to modulate the expression and/or production of numerous proteins, but also to...

Cite
Carullo G, Governa P, Spizzirri UG, et al. Sangiovese . Antioxidants (Basel). 2020;9(1)doi: 10.3390/antiox9010054.
Carullo, G., Governa, P., Spizzirri, U. G., Biagi, M., Sciubba, F., Giorgi, G., Loizzo, M. R., Di Cocco, M. E., Aiello, F., & Restuccia, D. (2020). Sangiovese . Antioxidants (Basel, Switzerland), 9(1), . https://doi.org/10.3390/antiox9010054
Carullo, Gabriele, et al. "Sangiovese ." Antioxidants (Basel, Switzerland) vol. 9,1 (2020). doi: https://doi.org/10.3390/antiox9010054
Carullo G, Governa P, Spizzirri UG, Biagi M, Sciubba F, Giorgi G, Loizzo MR, Di Cocco ME, Aiello F, Restuccia D. Sangiovese . Antioxidants (Basel). 2020 Jan 08;9(1). doi: 10.3390/antiox9010054. PMID: 31936207; PMCID: PMC7022605.
Copy Download .nbib Format: NLM
Assessing the utility of an IoS application in the perioperative care of spine surgery patients: the NeuroPath Pilot study.

mHealth

Glauser G, Ali ZS, Gardiner D, Ramayya AG, Pessoa R, Grady MS, Welch WC, Zager EL, Sim E, Haughey V, Wells B, Restuccia M, Tait G, Fala G, Malhotra NR.
PMID: 31620467
Mhealth. 2019 Sep 24;5:40. doi: 10.21037/mhealth.2019.09.01. eCollection 2019.

BACKGROUND: In an attempt to improve care while decreasing costs and postoperative pain, we developed a novel IoS mobile health application, NeuroPath. The objective of this innovative app is to integrate enhanced recovery after surgery (ERAS) principles, patient education,...

Cite
Glauser G, Ali ZS, Gardiner D, et al. Assessing the utility of an IoS application in the perioperative care of spine surgery patients: the NeuroPath Pilot study. Mhealth. 2019;5:40doi: 10.21037/mhealth.2019.09.01.
Glauser, G., Ali, Z. S., Gardiner, D., Ramayya, A. G., Pessoa, R., Grady, M. S., Welch, W. C., Zager, E. L., Sim, E., Haughey, V., Wells, B., Restuccia, M., Tait, G., Fala, G., & Malhotra, N. R. (2019). Assessing the utility of an IoS application in the perioperative care of spine surgery patients: the NeuroPath Pilot study. mHealth, 540. https://doi.org/10.21037/mhealth.2019.09.01
Glauser, Gregory, et al. "Assessing the utility of an IoS application in the perioperative care of spine surgery patients: the NeuroPath Pilot study." mHealth vol. 5 (2019): 40. doi: https://doi.org/10.21037/mhealth.2019.09.01
Glauser G, Ali ZS, Gardiner D, Ramayya AG, Pessoa R, Grady MS, Welch WC, Zager EL, Sim E, Haughey V, Wells B, Restuccia M, Tait G, Fala G, Malhotra NR. Assessing the utility of an IoS application in the perioperative care of spine surgery patients: the NeuroPath Pilot study. Mhealth. 2019 Sep 24;5:40. doi: 10.21037/mhealth.2019.09.01. eCollection 2019. PMID: 31620467; PMCID: PMC6789206.
Copy Download .nbib Format: NLM
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models.

Cancers

Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Pompili S, Vitale F, Martellucci S, Marampon F, Mattei V, Biordi L, Sherris D, Festuccia C.
PMID: 31640252
Cancers (Basel). 2019 Oct 21;11(10). doi: 10.3390/cancers11101604.

No abstract available.

Cite
Gravina GL, Mancini A, Colapietro A, et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers (Basel). 2019;11(10)doi: 10.3390/cancers11101604.
Gravina, G. L., Mancini, A., Colapietro, A., Delle Monache, S., Sferra, R., Pompili, S., Vitale, F., Martellucci, S., Marampon, F., Mattei, V., Biordi, L., Sherris, D., & Festuccia, C. (2019). The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers, 11(10), . https://doi.org/10.3390/cancers11101604
Gravina, Giovanni Luca, et al. "The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models." Cancers vol. 11,10 (2019). doi: https://doi.org/10.3390/cancers11101604
Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Pompili S, Vitale F, Martellucci S, Marampon F, Mattei V, Biordi L, Sherris D, Festuccia C. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers (Basel). 2019 Oct 21;11(10). doi: 10.3390/cancers11101604. PMID: 31640252; PMCID: PMC6826425.
Copy Download .nbib Format: NLM
Interfacial Charge Density and Its Connection to Adhesion and Frictional Forces.

Physical review letters

Wolloch M, Levita G, Restuccia P, Righi MC.
PMID: 30085711
Phys Rev Lett. 2018 Jul 13;121(2):026804. doi: 10.1103/PhysRevLett.121.026804.

We derive a connection between the intrinsic tribological properties and the electronic properties of a solid interface. In particular, we show that the adhesion and frictional forces are dictated by the electronic charge redistribution occurring due to the relative...

Cite
Wolloch M, Levita G, Restuccia P, et al. Interfacial Charge Density and Its Connection to Adhesion and Frictional Forces. Phys Rev Lett. 2018;121(2):026804doi: 10.1103/PhysRevLett.121.026804.
Wolloch, M., Levita, G., Restuccia, P., & Righi, M. C. (2018). Interfacial Charge Density and Its Connection to Adhesion and Frictional Forces. Physical review letters, 121(2), 026804. https://doi.org/10.1103/PhysRevLett.121.026804
Wolloch, M, et al. "Interfacial Charge Density and Its Connection to Adhesion and Frictional Forces." Physical review letters vol. 121,2 (2018): 026804. doi: https://doi.org/10.1103/PhysRevLett.121.026804
Wolloch M, Levita G, Restuccia P, Righi MC. Interfacial Charge Density and Its Connection to Adhesion and Frictional Forces. Phys Rev Lett. 2018 Jul 13;121(2):026804. doi: 10.1103/PhysRevLett.121.026804. PMID: 30085711.
Copy Download .nbib Format: NLM
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review.

Clinical rheumatology

Talotta R, Porrello I, Restuccia R, Magaudda L.
PMID: 34665346
Clin Rheumatol. 2021 Oct 19; doi: 10.1007/s10067-021-05954-7. Epub 2021 Oct 19.

Idiopathic inflammatory myopathies (IIM) are rare diseases affecting skeletal muscles and leading to progressive muscle weakness and disability. Thanks to the better understanding of their pathogenesis, the management of IIM has been noteworthily implemented in recent years. Current therapeutic...

Cite
Talotta R, Porrello I, Restuccia R, et al. Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review. Clin Rheumatol. 2021;doi: 10.1007/s10067-021-05954-7.
Talotta, R., Porrello, I., Restuccia, R., & Magaudda, L. (2021). Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review. Clinical rheumatology, . https://doi.org/10.1007/s10067-021-05954-7
Talotta, Rossella, et al. "Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review." Clinical rheumatology vol. (2021). doi: https://doi.org/10.1007/s10067-021-05954-7
Talotta R, Porrello I, Restuccia R, Magaudda L. Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review. Clin Rheumatol. 2021 Oct 19; doi: 10.1007/s10067-021-05954-7. Epub 2021 Oct 19. PMID: 34665346.
Copy Download .nbib Format: NLM
Altering the Properties of Graphene on Cu(111) by Intercalation of Potassium Bromide.

ACS nano

Schulzendorf M, Hinaut A, Kisiel M, Jöhr R, Pawlak R, Restuccia P, Meyer E, Righi MC, Glatzel T.
PMID: 30983325
ACS Nano. 2019 May 28;13(5):5485-5492. doi: 10.1021/acsnano.9b00278. Epub 2019 Apr 17.

The catalytic growth on transition metal surfaces provides a clean and controllable route to obtain defect-free, monocrystalline graphene. However, graphene's optical and electronic properties are diminished by the interaction with the metal substrate. One way to overcome this obstacle...

Cite
Schulzendorf M, Hinaut A, Kisiel M, et al. Altering the Properties of Graphene on Cu(111) by Intercalation of Potassium Bromide. ACS Nano. 2019;13(5):5485-5492doi: 10.1021/acsnano.9b00278.
Schulzendorf, M., Hinaut, A., Kisiel, M., Jöhr, R., Pawlak, R., Restuccia, P., Meyer, E., Righi, M. C., & Glatzel, T. (2019). Altering the Properties of Graphene on Cu(111) by Intercalation of Potassium Bromide. ACS nano, 13(5), 5485-5492. https://doi.org/10.1021/acsnano.9b00278
Schulzendorf, Mathias, et al. "Altering the Properties of Graphene on Cu(111) by Intercalation of Potassium Bromide." ACS nano vol. 13,5 (2019): 5485-5492. doi: https://doi.org/10.1021/acsnano.9b00278
Schulzendorf M, Hinaut A, Kisiel M, Jöhr R, Pawlak R, Restuccia P, Meyer E, Righi MC, Glatzel T. Altering the Properties of Graphene on Cu(111) by Intercalation of Potassium Bromide. ACS Nano. 2019 May 28;13(5):5485-5492. doi: 10.1021/acsnano.9b00278. Epub 2019 Apr 17. PMID: 30983325.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 85 entries